Search

everythinglearnresearchcommunity

for

Search:↓

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Canakinumab's effect on COVID-19 outcomes is unclear.

Juvenile dermatomyositis can worsen quickly and needs strong treatment.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Hair growth phase in mice weakens certain immune responses.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Intralesional triamcinolone acetonide is preferred for treating patchy alopecia areata due to fewer side effects.

Most patients with dermatomyositis had skin rash, itching, and muscle weakness, treated mainly with prednisolone and hydroxychloroquine.

Understanding androgen receptors, oxidative stress, and inflammation is key to developing better skin disease treatments.

Overexpressing the glucocorticoid receptor in mice leads to abnormal skin development and reduced inflammation.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.